CLINICAL ROLE -
Precision Medicine Opens New Possibilities to Treat Rheumatoid Arthritis
Genetic sequencing of joint biopsies may identify which patients with rheumatoid arthritis may respond to therapy.
Read More
Nintedanib Gains Fast Track Designation for Systemic Sclerosis
Nintedanib (Ofev) is currently indicated to slow disease progression among patients with idiopathic pulmonary fibrosis.
Experimental Antibody-Drug Conjugate for Lung Cancer Performs Poorly in Phase 2 Trials
AbbVie will not seek accelerated approval of Rovalpituzumab Tesirine as a third-line therapy for small cell lung cancer.
Trending News Today: New Budget Bill Won't Stabilize the ACA
Top news of the day from across the health care landscape.
Trending News Today: Modified Pap Test Could Detect Cervical, Ovarian, Endometrial Cancers
Nilotinib Approved to Treat Pediatric Patients with Leukemia
Nilotinib (Tasigna) was previously granted priority review for the treatment of pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia.
Low-Dose Viagra Could Keep Colorectal Cancer at Bay
Daily doses of sildenafil (Viagra) cut the development of polyps by 50% in mouse models.
Shorter HCV Regimen Effective in Black Patients
Black patients may be eligible for a shorter course of hepatitis C virus treatment.
Monoclonal Antibody Lowers Risk of Cardiovascular Events
Biologic drug cannakinumab found to reduce the risk of cardiovascular adverse events among patients with comorbidities.
Lifetime Sun Exposure May Reduce Multiple Sclerosis Risk
Individuals who experience high sun exposure during childhood or young adulthood may be less likely to develop multiple sclerosis.
Dietary Schedule May Benefit Patients with Huntington Disease
A cellular process could be key to lowering levels of the Huntington disease protein.
Trending News Today: Opioids Represent a Majority of Prescriptions in Some States
Trending News Today: Right-to-Try Bill Passed in House
FDA Approves Novel Biologic for Plaque Psoriasis
Tildrakizumab-asmn (Ilumya) approved for the treatment of moderate-to-severe plaque psoriasis.
Tecentriq Plus Chemotherapy May Reduce Disease Progression in NSCLC
The addition of atezolizumab (Tecentriq) to chemotherapy may improve outcomes for patients with advanced non-small cell lung cancer.
Novel Radioactive Tracer Could Predict Response to Lung Cancer Drugs
A PET scan could quickly indicate whether EGRF-targeted therapy would be beneficial to patients with non-small cell lung cancer.
Antiviral May Not Reduce Mother-to-Child Hepatitis B Transmission
Adding tenofovir disoproxil fumarate to prevention regimens may not effectively stop hepatitis B virus transmission to infants.
Colorectal Cancer Screening Should Consider Environmental, Genetic Factors
Standard colorectal cancer screening guidelines may not accurately assess risks in certain patients.
Trending News Today: NIH Launches Partnership to Fund Opioid Research
Trending News Today: First Patient With Inherited Blindness Treated with Luxterna
FDA Approves Adcetris as First-line Combination Therapy for Classical Hodgkin Lymphoma
Brentuximab vedotin (Adcetris) plus chemotherapy may lead to better disease outcomes for patients with classical Hodgkin lymphoma.
FDA Greenlights Adcetris as First-line Combination Therapy for Classical Hodgkin Lymphoma
Physicians: Prior Authorization Impedes Patient Outcomes
American Medical Association survey shows need for reform of the prior authorization process.
Cardiovascular Drugs May Lower Heart Disease Risk from Breast Cancer Chemotherapy
Lisinopril or carvedilol may protect breast cancer patients from experiencing a decline in heart function.
Oral Precancerous Lesions Raise Cancer Risk of Non-Smokers
Tobacco may not be to blame for aggressive oral cancers, a new study suggests.
Investigational Primary Progressive MS Drug Shows Safety, But No Efficacy Benefits
Idebenone was not found to delay disease progression in multiple sclerosis compared with placebo.
Trending News Today: Trump to Propose Multiple Bills Targeting Drug Costs
Trending News Today: Checkpoint Inhibitor Autoimmune Adverse Events Largely a Mystery
Artificial Sweetener May Exacerbate Inflammatory Bowel Disease
A popular sweetener could result in bacterial overgrowth and symptom worsening among patients with Crohn disease.
Erdafitinib Gains FDA Breakthrough Designation for Urothelial Cancer
Pan-fibroblast growth factor receptor tyrosine kinase inhibitor demonstrates efficacy in urothelial cancer.